Ligand Pharma (LGND)

Ligand Pharma (LGND) Balance Sheet


Ligand Pharma Balance Sheet

Ligand Pharma's total assets for Q2 2023 were $758.11M, a decrease of -6.53% from the previous quarter. LGND total liabilities were $93.21M for the fiscal quarter, a -43.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 762.67M$ 1.30B$ 1.36B$ 1.49B$ 1.26B
Total Liabilities
$ 165.18M$ 476.43M$ 652.76M$ 727.68M$ 699.89M
Total Equity Gross Minority
$ 597.49M$ 821.16M$ 709.52M$ 767.23M$ 560.91M
Total Capitalization
$ 597.49M$ 1.14B$ 1.15B$ 1.41B$ 1.17B
Preferred Stock Equity
Capital Lease Obligations
--$ 14.12M$ 11.22M$ 0.00
Currency in USD

Ligand Pharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis